COVID-19 vaccines transition to the National Immunisation Program
Home / News & Opportunities / Latest news / Current post
October 1, 2026
From 1 October 2026, COVID-19 vaccines will be funded under the National Immunisation Program (NIP), replacing the National COVID-19 Vaccine Program (NCVP) that was established during Australia’s response to the COVID-19 pandemic.
- States and territories will manage ordering, distribution, reporting and program support for COVID-19 vaccines under the NIP, in line with routine processes of other NIP vaccines.
- Funded vaccines will be available for eligible high-risk groups.
Free COVID-19 vaccines will be available under the NIP for:
- all adults aged 75 years and over (one dose approximately every 6 months)
- adults aged 65–74 years (one dose every 12 months)
- Aboriginal and Torres Strait Islander people aged 50–74 years (one dose every 12 months)
- all adults aged 18 years and over with severe immuno-compromise (one dose every 12 months).
People who are not eligible for a funded COVID-19 vaccine may choose to purchase the vaccine privately based on a benefit-risk discussion with their healthcare provider.
Healthcare professionals are encouraged to read the updates in the Australian Immunisation Handbook and the Department of Health, Disability and Ageing's COVID-19 Program NIP transition–advice for health professionals factsheet.
Latest news
Mornington Peninsula-based practice Fernbank has become the first non-traditional general practice in south east Melbourne to achieve accreditation – an important milestone for a two-person practice delivering care entirely within residential aged care homes.
SEMPHN-approved research supported by de-identified general practice data from POLAR has contributed to an important update to national vaccine safety information.
18 October marks World Menopause Day, an annual opportunity to raise global awareness, reduce stigma and provide education around perimenopause and menopause.
